AIDS INFORMATION NEWSLETTER Michael Howe, MSLS, Editor AIDS Information Center VA Medical Center, San Francisco (415) 221-4810 ext 3305 June 16, 1995 Opportunistic Infections (Part II) [Editor's Note: This is the first of three parts of a bibliography that includes references for review articles for opportunistic infections. The general outline of the bibliography, which will also be the outline for the series, is below and precedes the list of references.] Review Articles - Bibliography Outline I. Overview Articles II. Clinical Syndromes A. Diarrhea, Malabsorption, Wasting B. Dermatitis C. Fever III. Infections - Fungal A. Drugs B. Candidiasis C. Coccidioidomycosis D. Cryptococcosis E. Histoplasmosis IV. Infections - Mycobacterial A. Mycobacterium avium Complex B. Tuberculosis V. Infections - Parasitic A. Review Articles - General B. Cryptosporidiosis C. Pneumocystis carinii Pneumonia D. Toxoplasmosis VI. Infections - Viral A. Drugs B. Cytomegalovirus C. Herpes Simplex/Zoster D. Progressive Multifocal Leukoencephalopathy VII. Infections - Other A. Syphilis/Neurosyphilis VIII. Malignancies A. Review Article - General B. Cervical Cancer C. Kaposi's sarcoma D. Non-Hodgkin's Lymphoma and Hodgkin's Disease E. Squamous Cell Carcinoma BIBLIOGRAPHY OF OI REVIEW ARTICLES I. Overview Articles 1. Decker CF. Masur H. Current Status of Prophylaxis for Opportunistic Infections in HIV-Infected Patients. AIDS. 1994;8:11-20. 2. Drugs for AIDS and Associated Infections. The Medical Letter on Drugs and Therapeutics. 1993 Sept;35(Issue 904):79-86. 3. Gallant JE. Moore RD. Chaisson RE. Prophylaxis for Opportunistic Infections in Patients with HIV Infection. Annals of Internal Medicine. 1994:120:932-944. 4. Glaser CA. Angulo FJ. Rooney JA. Animal-Associated Opportunistic Infections Among Persons Infected with the Human Immunodeficiency Virus. Clinical Infectious Diseases. 1994;18:14-24. 5. Lane HC. Recent Advances in the Management of AIDS- Related Opportunistic Infections. Annals of Internal Medicine. 1994;120:945-955. 6. Lee BL. Safrin S. Interactions and Toxicities of Drugs Used in Patients with AIDS. Clinical Infectious Diseases. 1992 Mar;14:773-9. 7. Smith GH. Treatment of Infections in the Patient with Acquired Immunodeficiency Syndrome. Archives of Internal Medicine. 1994;154:949-973. 8. VandenBriessche Thierry. Chuah MK. Morgan RA. Gene Therapy for Acquired Immune Deficiency Syndrome. AIDS Updates. 1994;7(4):1-14. II. CLINICAL SYNDROMES A. DIARRHEA, MALABSORPTION, WASTING 1. Asmuth DM. DeGirolami PC. Federman M. et al. Clinical Features of Microsporidiosis in Patients with AIDS. Clinical Infectious Diseases. 1994;18:819-25. 2. Cat LK. Coleman RL. Treatment for HIV Wasting Syndrome. Annals of Pharmacotherapy. 1994;28:595-597. 3. Coodley GO. Loveless MO. Merrill TM. The HIV Wasting Syndrome: A Review. Journal of Acquired Immune Deficiency Syndromes. 1994;7(7):681-694. 4. Gazzard BG. Diarrhea in Human Immunodeficiency Virus Antibody-Positive Patients. Seminars in Liver Disease. 1992 Nov 2;12(2):154-166. 5. Grohmann GS. Glass RI. Pereira HG. et al. Enteric Viruses and Diarrhea in HIV-Infected Patients. New England Journal of Medicine. 1993;329(1):14-20. 6. Grunfeld C. Kotler DP. Pathophysiology of the AIDS Wasting Syndrome. In: Volberding P. Jacobson MA., Eds., AIDS Clinical Review 1992. New York: Marcel Dekker, Inc., 1992:191-224. 7. Grunfeld C. Kotler DP. Wasting in the Acquired Immunodeficiency Syndrome. Seminars in Liver Disease. 1992;12(2):175-87. 8. Keusch GT. Thea DM. Malnutrition in AIDS. Medical Clinics of North America. 1993 July;77(4):795-814. 9. Kotler DP. Wasting Syndrome: Nutritional Support in HIV Infection. AIDS Research and Human Retroviruses. 1994;10(8):931-934. 10. Mayer HB. Wanke CA. Diagnostic Strategies in HIV- Infected Patients with Diarrhea. AIDS. 1994;8:1639-1648. 11. McGowan I. Hawkins AS. Weller ID. The Natural History of Cryptosporidial Diarrhoea in HIV-Infected Patients. AIDS. 1993;7:349-54. 12. Molina JM. Sarfati C. Beavis B. et al. Intestinal Microsporidiosis in Human Immunodeficiency Virus Infected Patients with Chronic Unexplained Diarrhea: Prevalence and Clinical and Biologic Features. Journal of Infectious DIseases. 1993;167-217-21. 13. Rabeneck L. Diagnostic Workup Strategies for Patients with HIV-Related Chronic Diarrhea. Journal of Clinical Gastroenterology. 1993;16(3):245-50. 14. Rabeneck L. Gyorkey F. Genta RM. et al. The Role of Microsporidia in the Pathogenesis of HIV-Related Chronic Diarrhea. Annals of Internal Medicine. 1993;119(9):895- 9. 15. Simon D. Weiss LM. Brandt LJ. Treatment Options for AIDS- Related Esophageal and Diarrheal Disorders. American Journal of Gastroenterology. 1992;87(3):274-81. 16. Singer P. Katz DP. Dillon L. et al. Nutritional Aspects of the Acquired Immunodeficiency Syndrome. American Journal of Gastroenterology. 1992;87(3):265-73. 17. Von Roenn JH. Management of HIV-Related Bodyweight Loss. Drugs. 1994;47(5):774-783. 18. Wurtz R. Cyclospora: A Newly Identified Intestinal Pathogen of Humans. Clinical Infectious Diseases. 1994;18:620-3. B. DERMATITIS 1. Berger TG. Koehler JE. Bacillary Angiomatosis. In: AIDS Clinical Review 1993/1994. New York:Marcel Dekker, Inc., 1994:43-60. 2. Berger TG. Dermatological Aspects of HIV Disease: 1990 Update. AIDS. 1990;4(Suppl 1):S223-S225. 3. Cockerell CJ. Human Immunodeficiency Virus Infection and the Skin: A Crucial Interface. Archives of Internal Medicine. 1991 Jul;151:1295-1303. 4. Cockerell CJ. Organ-Specific Manifestations of HIV Infections. II. Update on Cutaneous Manifestations of HIV Infection. AIDS. 1993;7(Suppl 1):S213-S218. 5. Cotell SL. Noskin GA. Bacillary Angiomatosis: Clinical and Histologic Features, Diagnosis, and Treatment. Archives of Internal Medicine. 1994;154:524-528. 6. Dover JS. Johnson RA. Cutaneous Manifestations of Human Immunodeficiency Virus Infection. Archives of Dermatology. Part I. 1991 Sept;127:1383-1391. Part II. 1991 Oct;127:1549-1558. 7. Zalla MJ. Daniel WP. Fransway AF. Dermatologic Manifestations of Human Immunodeficiency Virus Infection. Mayo Clinic Proceedings. 1992 Nov;67:1089-1108. C. FEVER 1. Durack DT. Street AC. Fever of Unknown Origin--Reexamined and Redefined. Current Clinical Topics in Infectious Diseases. 1991;11:35-51. 2. Kirby AJ. Munoz A. Detels R. et al. Thrush and Fever as Measures of Immunocompetence in HIV-1 Infected Men. Journal of Acquired Immune Deficiency Syndromes. 1994;7:1242-1249. 3. Prego V. Glatt AE. Roy V. et al. Comparative Yield of Blood Culture for Fungi and Mycobacteria, Liver Biopsy, and Bone Marrow Biopsy in the Diagnosis of Fever of Undetermined Origin in Human Immunodeficiency Virus- Infected Patients. Archives of Internal Medicine. 1990 Feb;150:333-6. 4. Sepkowitz KA. Telzak EE. Carrow M. et al. Fever Among Outpatients with Advanced Human Immunodeficiency Virus Infection. Arch of Internal Medicine. 1993;153:1909-12. III. INFECTIONS - FUNGAL A. DRUGS 1. Armstrong D. Treatment of Opportunistic Fungal Infections. Clinical Infectious Diseases. 1993 Jan;16:1- 7. 2. Drugs for Treatment of Fungal Infections. The Medical Letter on Drugs and Therapeutics. 1992;34(Issue 864):14- 6. 3. Elmets CA. Management of Common Superficial Fungal Infections in Patients with AIDS. Journal of the American Academy of Dermatology. 1994;31:S60-S63. 4. Fluconazole. Medical Letter on Drugs & Therapeutics. 1990;32(818):50-2. 5. Itraconazole. The Medical Letter on Drugs and Therapeutics. 1993;35(Issue 888):7-9. 6. Stevens DA. Management of Systemic Manifestations of Fungal Disease in Patients with AIDS. Journal of the American Academy of Dermatology. 1994;31:S64-S67. 7. Systemic Antifungal Drugs. The Medical Letter on Drugs and Therapeutics. 1994;36(Issue 916):16-18. B. CANDIDIASIS 1. Garber GE. Fluconazole: A New Option in the Treatment of CAndida Mucositis and Esophageal Candidiasis. Journal of Otolaryngology. 1992;21(2):92-4. 2. Garber GE. Treatment of Oral Candida Mucositis Infections. Drugs. 1994;47(5):734-740. 3. Greenspan D. Treatment of Oral Candidiasis in HIV Infection. Oral Surgery Oral Medicine Oral Pathology. 1994;78:211-215. 4. Greenspan D. Treatment of Oropharyngeal Candidiasis in HIV-Positive Patients. Journal of the American Academy of Dermatology. 1994;31:S51-S55. 5. Katz MH. Greenspan D. Westenhouse J. et al. Progression to AIDS in HIV-Infected Homosexual and Bisexual Men with Hairy Leukoplakia and Oral Candidiasis. AIDS. 1992;6:95- 100. 6. Laine L. Dretler RH. Chris NC. Fluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS: A Randomized Trial. Annals of Internal Medicine. 1992;17:655-60. 7. McCarthy GM. Host Factors Associated With HIV-Related Oral Candidiasis: A Review. Oral Surgery, Oral Medicine, Oral Pathology. 1992 Feb;73(2):181-6. 8. Pons V. Greenspan D. Debruin M. and the Multicenter Study Group. Therapy for Oropharyngeal Candidiasis in HIV- Infected Patients: A Randomized, Prospective Multicenter Study of Oral Fluconazole Versus Clotrimazole Troches. Journal of Acquired Immune Deficiency Syndromes. 1993 Nov;6(12):1311-16. 9. Powderly WG. Resistant Candidiasis. AIDS Research and Human Retroviruses. 1994;10(8):925-929. 10. Samaramayake LP. Oral Mycoses in HIV Infection. Oral Surgery, Oral Medicine, Oral Pathology. 1992 Feb;73(2):171-80. 11. Sobel JD. Controversial Aspects in the Management of Vulvovaginal Candidiasis. Journal of the American Academy of Dermatology. 1994;31:S10-S13. C. COCCIDIOIDOMYCOSIS 1. Ampel NM. Dols CL. Galgiani JN. Coccidioidomycosis During Human Immunodeficiency Virus Infection: Results of a Prospective Study in a Coccidioidal Endemic Area. American Journal of Medicine. 1993 Mar;94;235-40. 2. Fish DG. Ampel NM. Galgiani JN. Cocidioidomycosis During Human Immunodeficiency Virus Infection: A Review of 77 Patients. Medicine. 1990;69(6):384-91. 3. Galgiani JN. Coccidioidomycosis: Changes in Clinical Expression, Serological Diagnosis, and Therapeutic Options. Clinical Infectious Diseases. 1992;14(Suppl 1):S100-5. 4. Galgiani JN. Catanzaro A. Cloud GA. et al. Fluconazole Therapy for Coccidioidal Meningitis. Annals of Internal Medicine. 1993 Jul;119(1):28-35. D. CRYPTOCOCCOSIS 1. Coker RJ. Viviani M. Gazzard BG. et al. Treatment of Cryptococcosis with Liposomal Amphotericin B (AmBisome) in 23 Patients with AIDS. AIDS. 1993;7(6):829-35. 2. Dismukes WE. Management of Cryptococcosis. Clinical Infectious Diseases. 1993;17(Suppl 2):S507-12. 3. Nelson MR. Fisher M. Cartledge J. et al. The Role of Azoles in the Treatment and Prophylaxis of Cryptococcal Disease in HIV Infection. AIDS. 1994;8:651-654. 4. Powderly WG. Cryptococcal Meningitis and AIDS. Clinical Infectious Diseases. 1993;17:837-42. 5. Powderly WG. New Developments in the Treatment of Cryptococcal Disease in AIDS. In: AIDS Clinical Review 1993/1994. New York: Marcel Dekker, Inc., 1994:113-28. 6. Powderly WG. Therapy for Cryptococcal Meningitis in Patients with AIDS. Clinical Infectious Diseases. 1992;14(Suppl 1):S54-9. 7. Powderly WG. Cloud GA. Dismukes WE. et al. Measurement of Cryptococcal Antigen in Serum and Cerebrospinal Fluid: Value in the Management of AIDS-Associated Cryptococcal Meningitis. Clinical Infectious Diseases. 1994;18:789- 92. 8. White M. Cirrincione C. Blevens A. et al. Cryptococcal Meningitis: Outcome in Patients with AIDS and Patients with Neoplastic Disease. Journal of Infectious Diseases. 1992;165:960-3. 9. White MH. Armstrong D. Cryptococcosis. Infectious Disease Clinics of North America. 1994;8(2):383-398. E. HISTOPLASMOSIS 1. Drew RH. Pharmacotherapy of Disseminated Histoplasmosis in Patients with AIDS. Annals of Pharmacotherapy. 1993 Dec;27:1510-8. 2. McKinsey DS. Driks MR. Histoplasmosis in HIV Disease. The AIDS Reader. 1993;3(6):203-9. 3. Norris S. Wheat J. McKinsey D. et al. Prevention of Relapse of Histoplasmosis with Fluconazole in Patients with the Acquired Immunodeficiency Syndrome. American Journal of Medicine. 1994;96:504-508. 4. Sarosi GA. Johnson PC. Disseminated Histoplasmosis in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 1992;14(Suppl 1):S60-7. 5. Sharkey-Mathis PK. Velez J. Fetchick R. et al. Histoplasmosis in the Acquired Immunodeficiency Syndrome (AIDS): Treatment with Itraconazole and Fluconazole. Journal of AIDS. 1993;6:809-19. 6. Wheat J. Histoplasmosis and Coccidioidomycosis in Individuals with AIDS: A Clinical Review. Infectious Disease Clinics of North America. 1994;8(20):467-482. 7. Wheat J. Histoplasmosis: Recognition and Treatment. Clinical Infectious Diseases. 1994;19(Suppl 1):S19-27. 8. Wheat J. Hafner R. Wulfsohn M. et al. Prevention of Relapse of Histoplasmosis with Itraconazole in Patients with the Acquired Immunodeficiency Syndrome. Annals of Internal Medicine. 1993 Apr;118(8):610-16. 9. Wheat LJ. Connolly-Stringfield PA. Baker RL. et al. Disseminated Histoplasmosis in the Acquired Immune Deficiency Syndrome: Clinical Findings, Diagnosis and Treatment, and Review of the Literature. Medicine. 1990 Nov;69(6):361-74.